Form 4 for LMAT LEMAITRE VASCULAR INC
Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-22 · accession 0001437749-24-036268 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-26 | 2024-11-22 | LMAT | LeMaitre George W | COB, CEO, Dir | M - OptEx | $39.03 | +2,818 | 1.89M | +0.1% | +$110.0K |
| D | 2024-11-26 | 2024-11-22 | LMAT | LeMaitre George W | COB, CEO, Dir | M - OptEx | $0.00 | -2,818 | 5,792 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-22 | M | A | 2,818 | $39.03 | 1,889,454 | D | — | — | (F1) Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-11-22 | M | D | 2,818 | $0.00 | 5,792 | D | $39.03 · 2019-12-20 to 2024-12-20 | 2,818 Common Stock | (F2) This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining four years. |